533 related articles for article (PubMed ID: 25750109)
21. Systematic review of quality of life following pleurectomy decortication and extrapleural pneumonectomy for malignant pleural mesothelioma.
Schwartz RM; Lieberman-Cribbin W; Wolf A; Flores RM; Taioli E
BMC Cancer; 2018 Nov; 18(1):1188. PubMed ID: 30497433
[TBL] [Abstract][Full Text] [Related]
22. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
[TBL] [Abstract][Full Text] [Related]
23. Outcome for patients with malignant pleural mesothelioma referred for Trimodality therapy in Western Australia.
Hasani A; Alvarez JM; Wyatt JM; Bydder S; Millward M; Byrne M; Musk AW; Nowak AK
J Thorac Oncol; 2009 Aug; 4(8):1010-6. PubMed ID: 19546819
[TBL] [Abstract][Full Text] [Related]
24. Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion for malignant pleural tumours: perioperative management and clinical experience.
Ried M; Potzger T; Braune N; Neu R; Zausig Y; Schalke B; Diez C; Hofmann HS
Eur J Cardiothorac Surg; 2013 Apr; 43(4):801-7. PubMed ID: 22885228
[TBL] [Abstract][Full Text] [Related]
25. Comorbidity, postoperative morbidity and survival in patients undergoing radical surgery for malignant pleural mesothelioma.
Infante M; Morenghi E; Bottoni E; Zucali P; Rahal D; Morlacchi A; Ascolese AM; De Rose F; Navarria P; Crepaldi A; Testori A; Voulaz E; Errico V; Perrino M; Scorsetti M; Chiti A; Santoro A; Alloisio M
Eur J Cardiothorac Surg; 2016 Dec; 50(6):1077-1082. PubMed ID: 27330149
[TBL] [Abstract][Full Text] [Related]
26. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma.
Krug LM; Pass HI; Rusch VW; Kindler HL; Sugarbaker DJ; Rosenzweig KE; Flores R; Friedberg JS; Pisters K; Monberg M; Obasaju CK; Vogelzang NJ
J Clin Oncol; 2009 Jun; 27(18):3007-13. PubMed ID: 19364962
[TBL] [Abstract][Full Text] [Related]
27. Surgical options in malignant pleural mesothelioma: extrapleural pneumonectomy or pleurectomy/decortication.
Flores RM
Semin Thorac Cardiovasc Surg; 2009; 21(2):149-53. PubMed ID: 19822286
[TBL] [Abstract][Full Text] [Related]
28. Updated meta-analysis of survival after extrapleural pneumonectomy versus pleurectomy/decortication in mesothelioma.
Magouliotis DE; Tasiopoulou VS; Athanassiadi K
Gen Thorac Cardiovasc Surg; 2019 Mar; 67(3):312-320. PubMed ID: 30374811
[TBL] [Abstract][Full Text] [Related]
29. Hemithoracic intensity modulated radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma: toxicity, patterns of failure, and a matched survival analysis.
Chance WW; Rice DC; Allen PK; Tsao AS; Fontanilla HP; Liao Z; Chang JY; Tang C; Pan HY; Welsh JW; Mehran RJ; Gomez DR
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):149-56. PubMed ID: 25442335
[TBL] [Abstract][Full Text] [Related]
30. Pleurectomy/decortication plus chemotherapy: outcomes of 40 cases of malignant pleural mesothelioma.
Colaut F; Toniolo L; Vicario G; Scapinello A; Visentin C; Manente P; Sartori CA
Chir Ital; 2004; 56(6):781-6. PubMed ID: 15771030
[TBL] [Abstract][Full Text] [Related]
31. Pleurectomy/decortication and hyperthermic intrapleural chemotherapy for malignant pleural mesothelioma: initial experience.
Migliore M; Calvo D; Criscione A; Palmucci S; Fuccio Sanzà G; Caltabiano R; Spatola C; Privitera G; Aiello MM; Parra HS; Ciancio N; Di Maria G
Future Oncol; 2015; 11(24 Suppl):19-22. PubMed ID: 26638918
[TBL] [Abstract][Full Text] [Related]
32. Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine followed by adjuvant chemotherapy in patients with malignant pleural mesothelioma.
Lang-Lazdunski L; Bille A; Belcher E; Cane P; Landau D; Steele J; Taylor H; Spicer J
J Thorac Oncol; 2011 Oct; 6(10):1746-52. PubMed ID: 21876457
[TBL] [Abstract][Full Text] [Related]
33. Clinical indications and results after chest wall resection for recurrent mesothelioma.
Burt BM; Ali SO; DaSilva MC; Yeap BY; Richards WG; Baldini EH; Sugarbaker DJ
J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1373-9; discussion 1379-80. PubMed ID: 24113019
[TBL] [Abstract][Full Text] [Related]
34. Intraoperative intracavitary hyperthermic chemotherapy for malignant pleural mesothelioma.
Okabe K
Ann Transl Med; 2017 Jun; 5(11):233. PubMed ID: 28706901
[TBL] [Abstract][Full Text] [Related]
35. [PLEURECTOMY/DECORTICATION].
Hashimoto M; Hasegawa S
Nihon Geka Gakkai Zasshi; 2016 Jul; 117(4):316-22. PubMed ID: 30160859
[TBL] [Abstract][Full Text] [Related]
36. Clinical experience of volumetric modulated arc therapy for malignant pleural mesothelioma after extrapleural pneumonectomy.
Kimura T; Doi Y; Nakashima T; Imano N; Katsuta T; Takahashi S; Kenjo M; Ozawa S; Murakami Y; Nagata Y
J Radiat Res; 2015 Mar; 56(2):315-24. PubMed ID: 25599996
[TBL] [Abstract][Full Text] [Related]
37. Types of surgery post-neoadjuvant chemotherapy for pleural mesothelioma.
Kuribayashi K; Doi H; Kijima T
Expert Rev Respir Med; 2019 Dec; 13(12):1189-1194. PubMed ID: 31596628
[No Abstract] [Full Text] [Related]
38. Malignant mesothelioma: current status and perspective in Japan and the world.
Hasegawa S; Tanaka F
Gen Thorac Cardiovasc Surg; 2008 Jul; 56(7):317-23. PubMed ID: 18607677
[TBL] [Abstract][Full Text] [Related]
39. Outcomes of Conversion to Extrapleural Pneumonectomy From Pleurectomy/Decortication for Malignant Pleural Mesothelioma.
Nakamura A; Hashimoto M; Matsumoto S; Kondo N; Kijima T; Hasegawa S
Semin Thorac Cardiovasc Surg; 2021; 33(3):873-881. PubMed ID: 33609685
[TBL] [Abstract][Full Text] [Related]
40. Systemic Therapy Use and Outcomes After Relapse from Preoperative Radiation and Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma.
Soldera SV; Kavanagh J; Pintilie M; Leighl NB; de Perrot M; Cho J; Hope A; Feld R; Bradbury PA
Oncologist; 2019 Jul; 24(7):e510-e517. PubMed ID: 30478189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
